Corporate News
EAACI Hybrid Congress 2022
July 2022
INMUNOTEK has participated in the commercial exhibition of the annual EAACI congress held in Prague (Czech Republic) on 1-3 July. Although it has also been held in hybrid form and hampered by the mobility restrictions that still exist in many countries, it has had a large number of attendees.
More info
50 Most Admired Companies to Watch 2022
April 2022
INMUNOTEK featured in CIO Bulletin's "50 Most Admired Companies to Watch 2022" list after being nominated for its business performance based on innovative and competitive products in the allergy and immunology fields.
More info
CIEGE 2021 Seal for Business Excellence
December 2021
INMUNOTEK obtains the CIEGE Seal for excellence in business management for the third consecutive year granted by Informa-ElEconomista. This Seal certifies excellent management over 57 indicators from 10 categories: solvency, profitability, growth, employment, internationalization, corporate social responsibility, customer satisfaction, innovation, commercial risk management and digitization.
More info
INMUNOTEK listed in CEPYME500 - 2021
November 2021
INMUNOTEK has once again been awarded the CEPYME500 seal in its 2021 edition, which recognizes the 500 leading Spanish companies in business growth, both for their results and their ability to generate added value, employment, innovation and international projection. This is the third year that INMUNOTEK has received this distinguished seal.
More info
INMUNOTEK, new CEOE member
November 2021
INMUNOTEK joins the CEOE as an associated member. This organization, which represents and defends the interests of Spanish companies, integrates most of the companies based in Spain, through different sectorial organizations or independently associated.
More info
